Modern Diagnostic & Research Centre (BOM:544673) Shareholder Yield % : -61.71% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544673 Modern Diagnostic & Research Centre Ltd BOM:544673
15 GF Score
Price ₹51.00
! 7 Warning Signs
View Full Analysis

What is Modern Diagnostic & Research Centre Shareholder Yield %?

Modern Diagnostic & Research Centre BOM:544673 15 Shareholder Yield % is -61.71% as of Mar. 2026. GuruFocus rates BOM:544673 with a GF Score™ of 15/100. The stock has 7 warning signs investors should review. Among 202 Medical Diagnostics & Research companies, Modern Diagnostic & Research Centre ranks worse than 96.04% on this metric.

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return. As of today, Modern Diagnostic & Research Centre's Shareholder Yield % was -61.71%.


Modern Diagnostic & Research Centre  (BOM:544673) Shareholder Yield % Explanation

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."

Shareholder Yield % is calculated by three components: Dividend Yield %, Buyback Yield %, and Net Debt Paydown Yield %.

Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.

Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.

Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.


Modern Diagnostic & Research Centre Shareholder Yield % Related Terms


Modern Diagnostic & Research Centre Shareholder Yield % Historical Data

* Premium members only.

The historical data trend for Modern Diagnostic & Research Centre's Shareholder Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Modern Diagnostic & Research Centre Shareholder Yield % Chart

Modern Diagnostic & Research Centre Annual Data
Trend Mar23 Mar24 Mar25 Mar26
Shareholder Yield %
0.00 0.00 0.00 -58.70

Modern Diagnostic & Research Centre Semi-Annual Data
Mar23 Mar24 Mar25 Mar26
Shareholder Yield % 0.00 0.00 0.00 -58.70

BOM:544673 vs TMO, DHR, IDXX: Shareholder Yield % Comparison

For the Diagnostics & Research subindustry, Modern Diagnostic & Research Centre's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Modern Diagnostic & Research Centre Shareholder Yield % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Modern Diagnostic & Research Centre's Shareholder Yield % distribution charts can be found below:

* The bar in red indicates where Modern Diagnostic & Research Centre's Shareholder Yield % falls into.


BOM:544673
15GF Score
Modern Diagnostic & Research Centre Ltd BOM:544673
Shareholder Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Modern Diagnostic & Research Centre Shareholder Yield % Calculation

Modern Diagnostic & Research Centre's Shareholder Yield % for the quarter that ended in Mar. 2026 is calculated as:

Shareholder Yield %=Dividend Yield %+Buyback Yield %+Net Debt Paydown Yield %
=0.00 %+-40.17 %+-18.53 %
=-58.7 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.

Frequently Asked Questions Learn more about Shareholder Yield % →
What does a Shareholder Yield % of -61.71% mean?
Modern Diagnostic & Research Centre (BOM:544673) has a Shareholder Yield % of -61.71% as of Mar. 2026. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Modern Diagnostic & Research Centre and its competitors. According to the industry distribution chart, Modern Diagnostic & Research Centre ranks #194 out of 202 companies in the Medical Diagnostics & Research industry, placing it in the top 96%.
Is Modern Diagnostic & Research Centre's Shareholder Yield % too high?
Modern Diagnostic & Research Centre's current Shareholder Yield % is -61.71%. Based on the distribution chart, Modern Diagnostic & Research Centre ranks #194 out of 202 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Modern Diagnostic & Research Centre has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Modern Diagnostic & Research Centre's Shareholder Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Modern Diagnostic & Research Centre ranks #194 out of 202 companies for Shareholder Yield %. This places Modern Diagnostic & Research Centre in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Medical Diagnostics & Research company?
A good Shareholder Yield % depends on the Medical Diagnostics & Research industry context. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Modern Diagnostic & Research Centre and its competitors. Modern Diagnostic & Research Centre's current Shareholder Yield % is -61.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Modern Diagnostic & Research Centre stock overvalued right now?
Modern Diagnostic & Research Centre (BOM:544673) has a current Shareholder Yield % of -61.71%. The current Shareholder Yield % is -61.71%. Modern Diagnostic & Research Centre's overall GF Score™ is 15/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For Modern Diagnostic & Research Centre (BOM:544673), the current Shareholder Yield % is -61.71% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Modern Diagnostic & Research Centre Business Description

Address New Railway Road, 363/4 Jawahar Nagar, Sadar Bazar, Gurugram, HR, IND, 122001
Modern Diagnostic & Research Centre Ltd is a services provider in diagnostic and related healthcare tests services in India. It offers a one-stop solution for pathology and radiology testing services such as imaging (including radiology), pathology/clinical laboratory. Through Its integrated, nationwide network, it offers a complete range of diagnostic facilities in radiology and pathology. The company provides healthcare tests and services for use in core testing, patients' diagnosis and prevention, monitoring of disease and other health conditions. Its customers include individual patients, hospitals and other healthcare providers and corporate customers.
15GF Score

Get the complete analysis for BOM:544673

Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹51.00
Price